Ayal Capital Advisors LTD Harrow Health, Inc. Transaction History
Ayal Capital Advisors LTD
- $350 Million
- Q4 2024
A detailed history of Ayal Capital Advisors LTD transactions in Harrow Health, Inc. stock. As of the latest transaction made, Ayal Capital Advisors LTD holds 45,000 shares of HROW stock, worth $1.37 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
45,000Holding current value
$1.37 Million% of portfolio
0.69%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding HROW
# of Institutions
187Shares Held
21.5MCall Options Held
650KPut Options Held
1.19M-
Opaleye Management Inc. Boston, MA3.99MShares$121 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$65.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$56.9 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$51.6 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$27.6 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $823M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...